Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus vaginal capsules plus metronidazole/fluconazole for bacterial vaginosis and vulvovaginal candidiasis
ChiCTR2500108208Phase 4Completed
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Aug 2025
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactobacillus vaginal capsules in bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) (4 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Microscopic examination of vaginal discharge. Started Aug 2025; status: completed.
02
Drugs
lactobacillus vaginal capsules
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on ChiCTR2500108208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108208.